NCT00222196View on ClinicalTrials.gov

Oslo Balloon Angioplasty Versus Conservative Treatment

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 30, 2000

Study Completion Date

December 31, 2004

Conditions
Peripheral Vascular Disease
Interventions
PROCEDURE

lifestyle, PTA

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

University Hospital, Aker

OTHER

collaborator

Pfizer

INDUSTRY

lead

Ullevaal University Hospital

OTHER

NCT00222196 - Oslo Balloon Angioplasty Versus Conservative Treatment | Biotech Hunter | Biotech Hunter